Navigation Links
First Reportable Data of EarlyCDT™-Lung Use in Clinical Practice Presented at IASLC World Conference on Lung Cancer
Date:7/5/2011

re not as precise as we would like and any tool that allows us to further risk stratify these nodules is of value," he added.  

Oncimmune's EarlyCDT-Lung test uses a panel of tumor antigens to detect the presence of immuno-biomarkers produced in the form of autoantibodies by the patient's immune system.  Elevation of any one of the panel of immuno-biomarkers (autoantibodies) above a predetermined cut-off value suggests that a tumor might be present and the lung nodule is malignant.  Previous studies have shown that immuno-biomarkers can be detected up to five years before tumors can be seen in routine diagnostic imaging procedures such as computed tomography (CT).

The audit included results from EarlyCDT-Lung's initial 6-antigen panel and the current 7-antigen panel that enables greater than 90% accuracy.  EarlyCDT-Lung has 93% specificity, resulting in seven times fewer false positives and three times better positive predictive value than CT. One thousand and ten (1010) patients in North America at high risk of lung cancer, on the basis of age and smoking history, from 293 centers across 40 states had EarlyCDT-Lung measured (start date May 2009). All patients signed a HIPAA release agreeing to their clinical information being accessed as part of this prospective audit.

According to John Robertson, M.D., FRCS, Chief Scientific Officer and founder of Oncimmune and Professor of Surgery, City Hospital, University of Nottingham, United Kingdom, "Collective data published in the Annals of Oncology, Clinical Cancer Research and an 'in press' manuscript with Cancer Prevention Research continue to demonstrate the depth of our scientific data and it
'/>"/>

SOURCE Oncimmune (USA) LLC
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... BURLINGTON, Mass. , May 21, 2013 ... leading research and advisory firms for pharmaceutical ... of an emerging agent on key efficacy ... disease progression, has the most influence over ... for advanced/metastatic hormone-receptor (HR-) positive, HER2-negative breast ...
(Date:5/21/2013)... CLARA, Calif. , May 21, 2013 ... game-changing embedded-ultrasound platform, today announced the introduction ... that allows complete network-based communications with all ... its latest embedded-ultrasound technology, including this new ... Sao Paulo, Brazil from ...
(Date:5/21/2013)... 21, 2013  The North Shore-LIJ Health System is ... hand-washing compliance at North Shore University Hospital in ... operating rooms at Forest Hills ... The new pilot program strengthens patient safety by ... (ORs), the first time in the US that remote ...
Breaking Medicine Technology:Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 3North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 4
... June 1, 2011 Mirixa Corporation is pleased to ... licensing agreement for MirixaEdge(SM), a clinical application that supports ... Medication Therapy Management (MTM). Family Physicians Group (FPG), ... Source Pharmacy and selected it as FPG,s preferred pharmacy ...
... YORK, June 1, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p0305172/Global-Intravenous-IV-Iron-Drugs-Industry.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ... Intravenous (IV) Iron Drugs in US$ Million. ...
Cached Medicine Technology:MirixaEdge(SM) to be Licensed by One Source Pharmacy, LLC 2MirixaEdge(SM) to be Licensed by One Source Pharmacy, LLC 3Global Intravenous (IV) Iron Drugs Industry 2Global Intravenous (IV) Iron Drugs Industry 3Global Intravenous (IV) Iron Drugs Industry 4Global Intravenous (IV) Iron Drugs Industry 5Global Intravenous (IV) Iron Drugs Industry 6Global Intravenous (IV) Iron Drugs Industry 7
(Date:5/21/2013)... May 2013 EMBO announced today that 52 outstanding ... its membership. Forty-three of the researchers reside in Europe ... of nine Associate Members from Canada, China, India, Japan ... around 1600 life scientists. , "Our members are the ... Director Maria Leptin said. "We have been building our ...
(Date:5/21/2013)... GA (PRWEB) May 21, 2013 ... ScripNet and Procura Management, today announced that it ... at Catamaran’s client advisory meeting. Conferred annually, ... partnered with Catamaran to create cutting edge programs ... year, Healthcare Solutions was recognized for its clinical ...
(Date:5/21/2013)... New York, NY (PRWEB) May 21, 2013 ... leukemia, melanoma or non-small cell lung cancer reported that ... behavior in their medicine use, according to new findings ... (NHWS), conducted by Kantar Health . The research ... Meeting for ISPOR (International Society for Pharmacoeconomics and Outcomes ...
(Date:5/21/2013)... A plastic surgery Internet marketing ... surgery SEO services following an Internet survey. , ... the “Best Plastic Surgery SEO Services”. , Sources ... predictable. Well-known in the plastic surgery Internet marketing ... any other selection based on superior client results. ...
(Date:5/21/2013)... It’s nearly summer and millions of kids will soon be ... or fall sports. In many cases a physical exam ... , To help parents during this busy time, MedSpring is ... physicals at just $29. As part of the ... perform a physical exam and complete required forms. Patients can ...
Breaking Medicine News(10 mins):Health News:EMBO announces 52 new members for 2013 2Health News:Healthcare Solutions Receives Innovation Award From Catamaran 2Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 2Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 3Health News:JD Media Surge's CosmeticSurgeonsOnline.com Voted #1 Source for Plastic Surgery SEO 2Health News:MedSpring Offers Camp and Sports Physicals For $29 2
... of his other colleagues in the industry with his huge list ... his tour of Europe. ,A source said that ... the tablets are quite difficult to get in Europe. ... are difficult to get in Europe," the Sun quoted the source, ...
... to a new review of studies,doctors are famous for ... of medication errors each year. Electronics to the ... entry systems saw a 66 percent drop in prescription ... are responsible for as much as 61 percent of ...
... Gullotta, said today that the review of childrens television standards by ... a ban on junk food advertising in childrens TV viewing times. ... to the ACMA review and he urged all groups concerned with ... ban on junk food advertising to kids must be a priority ...
... version of a molecule found in the egg cells of ... with the first drug treatment for brain tumours. ... tumour cell and binds to its surface before invading the ... to die. ,In new research published in the ...
... has found that fishes use the threat of punishment ... line and the social order stable. ,Their ... humans, has been hailed by some of the worlds leading ... the Proceedings of the Royal Society of London Series B. ...
... and soft drinks, may seem like harmless snacks and beverages, ... permanent damage to teeth. ,Its known as ... the effect of acid on the teeth that leads to ... of tooth erosion are fundamental to keeping teeth healthy for ...
Cached Medicine News:Health News:Computerized Doctors Order Reduce Prescription Errors 2Health News:Computerized Doctors Order Reduce Prescription Errors 3Health News:Brain Tumor Drug in Frogs A New Report 2Health News:Fishes Use Threat of Punishment in Mating Process 2Health News:Too Much of Acidic Foods can Cause Permanent Damage to Teeth 2
Open blade design with aspiration capabilities for removing fluids from the operative site....
Pediatric model. Spring-controlled spread of blades with locking mechanism. Dull finish. Blades: 11 mm....
Fenestrated blades with screw-controlled spread. Dull finish. Blades: 15 mm....
Replacement snares for the E3525. 3 per package....
Medicine Products: